Welcome to our dedicated page for CNO Financial Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CNO Financial Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CNO Financial Group's regulatory disclosures and financial reporting.
CNO Financial Group filed a Form 13F Holdings Report disclosing institutional holdings with a reported aggregate market value of $150,574,388 across 14 holdings. The filing lists one other included manager, 40|86 Advisors, Inc., and was signed on 11-13-2025.
CNO: A holder filed a Form 144 notice to sell up to 48,665 shares of common stock, with an aggregate market value $2,007,012.73. The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services as broker, an approximate sale date of 11/10/2025, and the NYSE as the exchange.
The shares were acquired via a stock option exercise on 11/10/2025 with cash payment. Shares outstanding were 95,353,512, providing baseline context.
CNO Financial Group reported Q3 2025 net income of $23.1 million, or $0.24 per diluted share, up from $9.3 million a year earlier, as revenues grew to $1,188.7 million from $1,129.6 million.
For the first nine months of 2025, net income fell to $136.4 million from $237.9 million, largely due to a $96.7 million non-cash impairment that fully wrote off goodwill of $69.5 million and $27.2 million of other intangibles tied to the Optavise benefits business.
At September 30, 2025, total assets were $38,296.2 million, with investments of $29,177.1 million and shareholders’ equity of $2,611.0 million. Operating cash flow for the nine-month period was $480.0 million, while the company returned capital via $259.9 million of share repurchases and $50.0 million in common dividends.
CNO Financial Group furnished an 8-K announcing its financial results for the quarter ended September 30, 2025. The company provided a press release, a quarterly financial supplement, and additional financial and operating information, all tied to Q3 2025 performance.
The materials were furnished under Item 2.02 and are not deemed filed for purposes of Section 18 of the Exchange Act. Investors can review the detailed exhibits for the full quarterly narrative and data.
- Exhibit 99.1: Press release (November 3, 2025)
- Exhibit 99.2: Quarterly Financial Supplement – Q3 2025
- Exhibit 99.3: Third Quarter 2025 Financial and Operating Results
- Exhibit 104: Cover Page Inline XBRL
BlackRock, Inc. filed Amendment No. 14 to Schedule 13G reporting beneficial ownership of 12,473,730 shares of CNO Financial Group common stock, representing 12.9% of the class as of the event date 09/30/2025.
BlackRock reports sole voting power over 12,106,902 shares and sole dispositive power over 12,473,730 shares, with no shared voting or dispositive power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. Various persons may have rights to dividends or sale proceeds through managed accounts, but no single person exceeds five percent of the outstanding common shares.
CNO Financial Group, Inc. furnished a Consumer Division Briefing investor presentation dated September 2025. The presentation is attached as Exhibit 99.1 and will also be posted in the Investors section of the company’s website at ir.CNOinc.com. The materials provide information on the company’s consumer division and are being furnished under the Securities Exchange Act of 1934 rather than filed, which affects how they are treated for liability purposes and whether they are incorporated into other SEC documents.
CNO Financial Group director Mary R. Henderson reported a sale of 6,300 shares of CNO common stock on 08/28/2025. The Form 4 shows the disposition was coded as a charitable donation and carried no cash proceeds (price $0). After the reported transaction, Ms. Henderson beneficially owned 73,460 shares in total, held directly.
The filing is a routine Section 16 disclosure by an insider and lists the transaction executor as Heidi M. Krings, Attorney-in-Fact, with a signature date of 08/29/2025. No options, derivatives, or other compensatory transactions are reported on this form.
Karen J. DeToro, President of the Worksite Division at CNO Financial Group (CNO), reported sales of common stock under a Rule 10b5-1 plan adopted May 6, 2025. The filing shows three separate dispositions on August 13-15, 2025 totaling 25,657 shares sold at weighted average prices of approximately $37.96, with reported per-trade weighted averages of $37.9588, $37.9788 and $37.8481. After these sales the reporting person beneficially owned 41,855 shares. The filing indicates the transactions were made pursuant to an affirmative-defense 10b5-1 plan and that detailed per-price breakdowns can be provided upon request.
CNO Financial Group insider filing (Form 4/A) shows that Karen J. DeToro, President of the Worksite Division and an officer of CNO (ticker: CNO), disposed of 1,417 shares of common stock on 01/02/2025. The shares were surrendered to the issuer to cover required tax withholding on vested restricted stock units, at an indicated price of $37.14 per share. Following the transaction, Ms. DeToro beneficially owned 58,918 shares. The filing is an amendment that corrects the amount disposed and the post-transaction beneficial ownership.
CNO Financial Group, Inc. (CNO) Form 144 reports a proposed sale of 9,228 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $349,262.27, based on an approximate sale date of 08/15/2025 on the NYSE. The filing lists total shares outstanding of 96,931,934. The securities were acquired as performance shares on 02/14/2023 (7,479 shares) and as restricted stock on 09/30/2021 (1,749 shares). The filer also reported recent sales: 6,509 shares on 08/14/2025 for $247,203.36 and 9,920 shares on 08/13/2025 for $376,551.30. The notice includes the standard representation regarding material nonpublic information and a broker identification.